StockWatch
·

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

BSE: 500660

Shareholding Trends

Ownership split

PromoterPublicOthers
0%28%56%84%Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27

Institutional detail

FII / FPIDII
2%5%7%9%Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27

Q2 FY27

Corporate Events

Board MeetingGLAXO
2026
3Nov

Board Meeting

The Board of Directors meeting is scheduled to consider, app…

BSE Filing ↗
Board MeetingGLAXO
2026
3Aug

Board Meeting

A meeting of the Board of Directors of our Company will be h…

BSE Filing ↗
Board MeetingGLAXO
2025
1Aug

Board Meeting

Board Meeting Intimation, Un-Audited Financial Results for t…

BSE Filing ↗
Board MeetingGLAXO
2025
14Feb

Board Meeting

Consider and approve Un-audited financial results for the th…

BSE Filing ↗
DividendGLAXO
2024
7Nov

₹12 / share

BSE Filing ↗
Board MeetingGLAXO
2024
29Oct

Board Meeting

consider and approve Unaudited financial results for the sec…

BSE Filing ↗
Board MeetingGLAXO
2024
2Aug

Board Meeting

Consider and approve Un-Audited Financial Results for the fi…

BSE Filing ↗
DividendGLAXO
2024
31May

₹32 / share

BSE Filing ↗
Board MeetingGLAXO
2024
12Feb

Board Meeting

consider and approve Un-Audited Financial Results for the th…

BSE Filing ↗
Board MeetingGLAXO
2023
9Nov

Board Meeting

Consideration and approval of Un-Audited Financial Results f…

BSE Filing ↗